Markets:

Overview

News

Currencies

International

Treasuries

CureVac N.V. - Ordinary Shares (NQ:CVAC)

4.480 +0.160 (+3.70%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 30, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about CureVac N.V. - Ordinary Shares

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Moderna and Pfizer May Benefit From This Rival's Bad News ↗

July 03, 2021

And it could equal billions of dollars for these vaccine leaders.

Via The Motley Fool

Topics Cannabis

Can CureVac Recover After Its Vaccine Setback? ↗

July 03, 2021

Investors' dreams of a third strong mRNA vaccine may be over.

Via The Motley Fool

Topics Cannabis

30 Stocks Moving In Thursday's Mid-Day Session ↗

July 01, 2021

Gainers Pop Culture Group Co., Ltd (NASDAQ: CPOP) shares jumped 104.6% to $62.00. Pop Culture Group shares jumped 405% on Wednesday after the company priced its IPO at $6 per...

Via Benzinga

Topics Initial Public Offering

Why CureVac Shares Are Trading Lower Today ↗

June 23, 2021

CureVac BV (NASDAQ:CVAC) shares are trading lower by 3.6% ...

Via Benzinga

CVAC Stock Price Increases 14%: Why It Happened ↗

June 18, 2021

CureVac BV (NASDAQ:CVAC) shares are trading higher by 14% ...

Via Benzinga

58 Biggest Movers From Yesterday ↗

July 02, 2021

Gainers The Glimpse Group, Inc. (NASDAQ: VRAR) shares jumped 152.3% to settle at $17.66 on Thursday after the company priced its IPO at $7 per share. Pop Culture Group Co., Ltd (...

Via Benzinga

Topics Initial Public Offering

Analyzing CureVac's Unusual Options Activity ↗

July 01, 2021

CureVac (NASDAQ:CVAC) shares experienced unusual options activity on Thursday. The stock price moved down to $68.53 following the option alert. Sentiment: BULLISH Option Type:...

Via Benzinga

20 Stocks Moving in Thursday's Pre-Market Session ↗

July 01, 2021

Gainers Alterity Therapeutics Ltd (NASDAQ: ATHE) shares rose 64% to $2.14 in pre-market trading. Alterity Therapeutics recently said it received EU regulatory guidance for ATH434...

Via Benzinga

The Daily Biotech Pulse: Spero Spikes On Pfizer Investment, FDA Nod For Jazz, Orchard Signs Licensing Deal, Acumen Pharma Debuts ↗

July 01, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 30) Ambrx Biopharma Inc. (NYSE...

Via Benzinga

A Peek Into The Markets: US Stock Futures Up Ahead Of Initial Jobless Claims Data ↗

July 01, 2021

Pre-open movers U.S. stock futures traded higher in early pre-market trade ahead of initial jobless claims data. The Dow Jones climbed over 200 points on Wednesday, while the S...

Via Benzinga

Topics Stocks

CureVac Stock Drops After Final Results Confirm Its COVID-19 Vaccine Trails Rivals ↗

July 01, 2021

The German biotech company CureVac BV (NASDAQ: CVAC) announced on Wednesday after hours the final results of its late-stage COVID-19 vaccine trial showing 48%...

Via Benzinga

CureVac Final Data from Phase 2b/3 Trial of First-Generation COVID-19 Vaccine Candidate, CVnCoV, Demonstrates Protection in Age Group of 18 to 60

June 30, 2021

- Unique pivotal study conducted in 10 countries in fast changing variant environment; 15 COVID-19 variant strains present for efficacy analysis; original strain almost completely absent - Statistical...

From CureVac

Via AccessWire

Topics Intellectual Property Regulatory Compliance

CureVac Announces Appointment of Dr. Malte Greune as Chief Operating Officer and Transition of Dr. Florian von der Mülbe to Lead Accelerated Development of The RNA Printer(R)

June 30, 2021

TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / June 30, 2021 / CureVac N.V. (NASDAQ:CVAC), a global clinical-stage biopharmaceutical company developing a new class of transformative medicines based on...

From CureVac

Via AccessWire

Topics Intellectual Property Regulatory Compliance

June’s Best and Worst Performing Russell 1,000 Stocks ↗

June 29, 2021

The month of June, the second quarter and the first half of 2021 are almost in the bag.

Via Talk Markets

Without a Coronavirus Vaccine Of Its Own, Is There Any Hope For CureVac Stock? ↗

June 29, 2021

Things are looking bleak right now, but they might improve with enough time.

Via The Motley Fool

CureVac Announces Voting Results of General Meeting

June 25, 2021

TÜBINGEN, GERMANY andBOSTON, MA / ACCESSWIRE / June 25, 2021 / CureVac N.V. (NASDAQ:CVAC), a global clinical-stage biopharmaceutical company developing a new class of transformative medicines based on...

From CureVac

Via AccessWire

Topics Intellectual Property Regulatory Compliance

CureVac Provides Supervisory Board Update

June 23, 2021

TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / June 23, 2021 / CureVac N.V. (NASDAQ:CVAC), a global clinical-stage biopharmaceutical company developing a new class of transformative medicines based on...

From CureVac

Via AccessWire

Topics Intellectual Property Regulatory Compliance

Could CureVac Be a Millionaire-Maker Stock? ↗

June 23, 2021

CureVac's first COVID vaccine candidate disappointed investors. But a second one looks promising.

Via The Motley Fool

How Pfizer and Moderna Could Profit Big-Time From AstraZeneca's and CureVac's Challenges ↗

June 23, 2021

Bad news for AstraZeneca and CureVac should mean more good news for Pfizer and Moderna.

Via The Motley Fool

Europe Purchases Additional 150M Doses Of Moderna COVID-19 Vaccine ↗

June 22, 2021

The European Union has decided to take up an option under a supply contract with Moderna Inc (NASDAQ: MRNA) that allows the bloc to order 150 million...

Via Benzinga

Why Is Everyone Talking About CureVac Stock? ↗

June 21, 2021

This coronavirus vaccine developer just hit a massive stumbling block.

Via The Motley Fool

The Week Ahead In Biotech: Incyte, Ascendis FDA Decisions, Liver Congress Presentations And 4 IPOs ↗

June 20, 2021

Biotech stocks came under pressure in the week ended June 18, dragged by the negative sentiment that prevailed in the broader market due to macroeconomic worries. The U.S. Federal...

Via Benzinga

58 Biggest Movers From Friday ↗

June 21, 2021

Gainers CAI International, Inc. (NYSE: CAI) shares surged 46.9% to close at $56.05 on Friday after the company agreed to a $1.1 billion takeover by Mitsubishi HC Capital Inc....

Via Benzinga

Stock Market Rally Shifts To Tech After Fed Meeting; Adobe, Ford In Focus: Weekly Review ↗

June 18, 2021

Techs seized stock market leadership, despite the Fed signaling earlier rate hikes. But many real economy names dived.

Via Investor's Business Daily

Topics Economy Stocks

32 Stocks Moving In Friday's Mid-Day Session ↗

June 18, 2021

Gainers CAI International, Inc. (NYSE: CAI) shares jumped 46.4% to $55.86 after the company agreed to a $1.1 billion takeover by Mitsubishi HC Capital Inc. Sykes Enterprises,...

Via Benzinga

28 Stocks Moving in Friday's Pre-Market Session ↗

June 18, 2021

Gainers CAI International, Inc. (NYSE: CAI) rose 45.1% to $55.35 in pre-market trading after the company agreed to a $1.1 billion takeover by Mitsubishi HC Capital Inc. Geron...

Via Benzinga

12 Words From CureVac's CEO That Could Mean Billions for Moderna and Pfizer ↗

June 18, 2021

The news may reinforce Moderna's and Pfizer's vaccine-market dominance.

Via The Motley Fool

Topics Supply Chain

50 Biggest Movers From Yesterday ↗

June 18, 2021

Gainers Verve Therapeutics, Inc. (NASDAQ: VERV) shares surged 68% to settle at $31.92 on Thursday after the company priced its IPO at $19 per share. Midatech Pharma plc (NASDAQ...

Via Benzinga

Topics Initial Public Offering

Tesla Partner CureVac Says Will Find 'Sweet Spot' For COVID-19 Vaccine Despite Disappointing Data ↗

June 18, 2021

CureVac N.V.’s (NASDAQ: CVAC) Chief Financial Officer Pierre Kemula is optimistic its COVID-19 vaccine could still be offered to certain age groups or as a booster, the...

Via Benzinga

Mid-Afternoon Market Update: Nasdaq Gains Over 100 Points; CureVac Shares Plummet ↗

June 17, 2021

Toward the end of trading Thursday, the Dow traded down 0.67% to 33,806.27 while the NASDAQ rose 0.91% to 14,167.03. The S&P also fell, dropping 0.02% to 4,222.94. The U.S....

Via Benzinga

Topics Stocks

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.